Aaron Cox - 16 May 2022 Form 3 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP, Chief Financial Officer
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 May 2022
Net transactions value
$0
Form type
3
Filing time
16 May 2022, 18:05:12 UTC
Next filing
29 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HZNP Ordinary Shares 4,774 16 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HZNP Restricted Stock Units (RSU) 16 May 2022 Ordinary Shares 9,676 Direct F1
holding HZNP Restricted Stock Units (RSU) 16 May 2022 Ordinary Shares 18,628 Direct F2
holding HZNP Restricted Stock Units (RSU) 16 May 2022 Ordinary Shares 23,805 Direct F3
holding HZNP Performance Restricted Stock Units (PSU) 16 May 2022 Ordinary Shares 1,573 Direct F4
holding HZNP Performance Restricted Stock Units (PSU) 16 May 2022 Ordinary Shares 5,806 Direct F4
holding HZNP Performance Restricted Stock Units (PSU) 16 May 2022 Ordinary Shares 3,868 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The outstanding remaining shares vest on January 5, 2023.
F2 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The outstanding remaining shares vest in equal installments on January 5, 2023 and January 5, 2024.
F3 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The 23,805 ordinary shares subject to the restricted stock units vest ratably over three years on each anniversary of the grant date (January 4, 2022).
F4 Each performance restricted stock unit represents a contingent right to receive one ordinary share of the Issuer subject to satisfaction of certain performance criteria. The outstanding remaining shares vest on January 5, 2023.